Who is sponsoring NCT04427904?

NCT04427904 is sponsored by St. Joseph's Healthcare Hamilton.

What drugs are being tested in NCT04427904?

Interventions in NCT04427904: Bupivacaine 0.5% with 1:200 000 epinephrine, Lidocaine 2% with 1:100 000 epinephrine.

What condition does NCT04427904 study?

NCT04427904 studies Postoperative Pain, Thyroid Diseases, Anesthesia, Local.

Is NCT04427904 still recruiting?

NCT04427904 is currently status unknown. Last updated 28 November 2023.

Last reviewed 2023-11-28 · How we verify

NCT04427904

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bupivacaine Versus Lidocaine Infiltration for Postoperative Pain in Thyroid Surgery

Status unknown Phase 2 Last updated 28 November 2023

What this trial tests

Phase 2 trial testing Bupivacaine 0.5% with 1:200 000 epinephrine in Postoperative Pain in 210 participants. Status unknown.

Timeline

1 June 2022

Primary endpoint
31 December 2024

31 December 2025

Quick facts

Lead sponsor	St. Joseph's Healthcare Hamilton
Phase	Phase 2
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	210
Start date	1 June 2022
Primary completion	31 December 2024
Estimated completion	31 December 2025
Sites	1 location across Canada

Drugs / interventions tested

Bupivacaine 0.5% with 1:200 000 epinephrine — full drug profile →
Lidocaine 2% with 1:100 000 epinephrine — full drug profile →

Conditions studied

Postoperative Pain — all drugs for Postoperative Pain →
Thyroid Diseases — all drugs for Thyroid Diseases →
Anesthesia, Local — all drugs for Anesthesia, Local →

Sponsor

St. Joseph's Healthcare Hamilton — full company profile →

Who can join

Adults 18 to 100, any sex, with Postoperative Pain or Thyroid Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare the efficacy of Bupivicaine and Lidocaine for postoperative pain control in thyroid surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other St. Joseph's Healthcare Hamilton trials

Trials by the same sponsor.

NCT06638125 — 3-Dimensional Virtual Reality Modelling With Intravascular Indocyanine Green Fluorescence Mapping for Targeted Pulmonary · Phase 1, PHASE2 · not yet recruiting
NCT07495228 — Cognitive Processing Therapy for Childbirth-Related Post-Traumatic Stress Disorder · NA · not yet recruiting
NCT07387965 — A Brief Cannabis Use Psychoeducation Intervention for Eating Disorder Patients · NA · not yet recruiting
NCT07349316 — The Effects of Weight and Nutrition Education on Weight Control Beliefs, Body Image, Self-Esteem and Eating Patterns in · NA · not yet recruiting
NCT07250893 — Resolving Early Life Stress: Psychotherapy Outcomes and Neurobiology in Complex Depression · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04427904 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by St. Joseph's Healthcare Hamilton
Last refreshed: 28 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04427904.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing